Mark L. Chiu

6.2k total citations · 1 hit paper
89 papers, 4.1k citations indexed

About

Mark L. Chiu is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cell Biology. According to data from OpenAlex, Mark L. Chiu has authored 89 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 39 papers in Radiology, Nuclear Medicine and Imaging and 16 papers in Cell Biology. Recurrent topics in Mark L. Chiu's work include Monoclonal and Polyclonal Antibodies Research (31 papers), Protein purification and stability (16 papers) and Glycosylation and Glycoproteins Research (14 papers). Mark L. Chiu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (31 papers), Protein purification and stability (16 papers) and Glycosylation and Glycoproteins Research (14 papers). Mark L. Chiu collaborates with scholars based in United States, Belgium and Netherlands. Mark L. Chiu's co-authors include James F. Kronauge, David Piwnica‐Worms, Gary L. Gilliland, Dennis R. Goulet, A. Teplyakov, Reinhard Krämer, James M. Croop, Stephen G. Sligar, Sheri L. Moores and Gerd N. La Mar and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Circulation.

In The Last Decade

Mark L. Chiu

84 papers receiving 4.0k citations

Hit Papers

Antibody Structure and Function: The Basis for Engineerin... 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antibody Structure and Function: The Basis for Engineering Therapeutics
    2019 364 citations Mark L. Chiu, Dennis R. Goulet et al. Antibodies profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark L. Chiu United States 32 1.8k 1.8k 1.0k 659 427 89 4.1k
Pavel Strop United States 33 865 0.5× 2.5k 1.4× 680 0.7× 419 0.6× 465 1.1× 75 4.2k
Zahid N. Rabbani United States 37 1.2k 0.7× 2.8k 1.6× 846 0.8× 891 1.4× 417 1.0× 78 5.3k
Gillian M. Tozer United Kingdom 39 1.1k 0.6× 3.4k 1.9× 1.4k 1.4× 632 1.0× 473 1.1× 117 6.8k
Michael K. Wendt United States 41 738 0.4× 2.4k 1.4× 1.5k 1.5× 533 0.8× 602 1.4× 105 4.7k
Ludwig J. Dubois Netherlands 41 1.4k 0.8× 2.6k 1.5× 1.2k 1.1× 951 1.4× 488 1.1× 162 6.0k
Roberto Pacelli Italy 36 734 0.4× 949 0.5× 703 0.7× 688 1.0× 419 1.0× 123 3.8k
Simon P. Robinson United Kingdom 49 3.7k 2.0× 2.0k 1.2× 1.2k 1.2× 859 1.3× 344 0.8× 243 8.1k
Buck E. Rogers United States 40 1.7k 0.9× 1.8k 1.1× 2.0k 2.0× 610 0.9× 546 1.3× 126 5.0k
Rajani Ravi United States 35 907 0.5× 4.6k 2.6× 2.0k 2.0× 529 0.8× 887 2.1× 43 7.9k
Bryan C. Fuchs United States 40 442 0.2× 1.7k 1.0× 1.0k 1.0× 529 0.8× 205 0.5× 105 4.7k

Countries citing papers authored by Mark L. Chiu

Since Specialization
Citations

This map shows the geographic impact of Mark L. Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Chiu more than expected).

Fields of papers citing papers by Mark L. Chiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Chiu. The network helps show where Mark L. Chiu may publish in the future.

Co-authorship network of co-authors of Mark L. Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Chiu. A scholar is included among the top collaborators of Mark L. Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Chiu. Mark L. Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilski, Nicole A., et al.. (2025). A Dual-Payload Bispecific ADC Improved Potency and Efficacy over Single-Payload Bispecific ADCs. Pharmaceutics. 17(8). 967–967. 1 indexed citations
2.
3.
Yu, Mingcan, Peng Chen, Ying Jin, et al.. (2025). A Bispecific Antibody Blocking Both TSLP and IL-4Rα for the Treatment of Allergic Inflammatory Diseases. Cells. 14(22). 1747–1747.
4.
Zhou, Fulai, Hao Jiang, Shuting Dong, et al.. (2024). A Novel Dual-Fc Bispecific Antibody with Enhanced Fc Effector Function. Biochemistry. 63(8). 958–968. 2 indexed citations
5.
Han, Chao, Di Zhang, Ying Jin, et al.. (2024). Phase 1 Safety and Pharmacokinetics Study of TAVO101, an Anti‐Human Thymic Stromal Lymphopoietin Antibody for the Treatment of Allergic Inflammatory Conditions. The Journal of Clinical Pharmacology. 65(1). 28–40. 3 indexed citations
6.
Tornetta, Mark, Brian Whitaker, Lu Han, et al.. (2024). The process using a synthetic library that generates multiple diverse human single domain antibodies. PubMed. 7(4). 283–294.
7.
8.
Huang, Yihung, et al.. (2022). GFR Estimation in Potential Living Kidney Donors: Race- and Nonrace-based Equations and Measured GFR. Kidney Medicine. 4(12). 100558–100558. 6 indexed citations
9.
Zwolak, Adam, Szeman Ruby Chan, Anthony A. Armstrong, et al.. (2022). A stable, engineered TL1A ligand co-stimulates T cells via specific binding to DR3. Scientific Reports. 12(1). 20538–20538. 5 indexed citations
10.
Neijssen, Joost, Rosa M. F. Cardoso, Kristen Chevalier, et al.. (2021). Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET. Journal of Biological Chemistry. 296. 100641–100641. 118 indexed citations
11.
Chiu, Mark L., Dennis R. Goulet, A. Teplyakov, & Gary L. Gilliland. (2019). Antibody Structure and Function: The Basis for Engineering Therapeutics. Antibodies. 8(4). 55–55. 364 indexed citations breakdown →
12.
Chornoguz, Olesya, et al.. (2019). Characterization of a Novel Bispecific Antibody That Activates T Cells In Vitro and Slows Tumor Growth In Vivo. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 38(6). 242–254. 3 indexed citations
13.
Hinke, Simon A., Thomas Kirchner, Katharine D’Aquino, et al.. (2018). Unique pharmacology of a novel allosteric agonist/sensitizer insulin receptor monoclonal antibody. Molecular Metabolism. 10. 87–99. 12 indexed citations
14.
Zwolak, Adam, Susan H. Tam, Dennis R. Goulet, et al.. (2017). Rapid Purification of Human Bispecific Antibodies via Selective Modulation of Protein A Binding. Scientific Reports. 7(1). 15521–15521. 22 indexed citations
15.
Labrijn, Aran F., Joyce Meesters, Matthew W. Bunce, et al.. (2017). Efficient Generation of Bispecific Murine Antibodies for Pre-Clinical Investigations in Syngeneic Rodent Models. Scientific Reports. 7(1). 2476–2476. 31 indexed citations
16.
Moores, Sheri L., Mark L. Chiu, Barbara S. Bushey, et al.. (2016). A Novel Bispecific Antibody Targeting EGFR and cMet Is Effective against EGFR Inhibitor–Resistant Lung Tumors. Cancer Research. 76(13). 3942–3953. 188 indexed citations
17.
Chiu, Mark L., et al.. (1997). The carboxyl-terminal valine residues of proTGF alpha are required for its efficient maturation and intracellular routing.. Molecular Biology of the Cell. 8(8). 1619–1631. 69 indexed citations
18.
Pin, Serge, Bernard Alpert, R. Cortès, et al.. (1994). The Heme Iron Coordination Complex in His64(E7)Tyr Recombinant Sperm Whale Myoglobin. Biochemistry. 33(38). 11618–11623. 9 indexed citations
19.
Kronauge, James F., Mark L. Chiu, Alan Davison, et al.. (1992). Comparison of neutral and cationic myocardial perfusion agents: Characteristics of accumulation in cultured cells. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 19(2). 141–148. 22 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pavel Strop Breakdown of academic impact, for papers by Zahid N. Rabbani Breakdown of academic impact, for papers by Gillian M. Tozer Breakdown of academic impact, for papers by Michael K. Wendt Breakdown of academic impact, for papers by Ludwig J. Dubois Breakdown of academic impact, for papers by Roberto Pacelli Breakdown of academic impact, for papers by Simon P. Robinson Breakdown of academic impact, for papers by Buck E. Rogers Breakdown of academic impact, for papers by Rajani Ravi Breakdown of academic impact, for papers by Bryan C. Fuchs
Rankless by CCL
2026